Gene · 3822
Papers2,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging. | Pharmaceutics | 2023 | 36986778 | PubTator, text mining | PubMed |
| The Role of NK Cells in EBV Infection and Related Diseases: Current Understanding and Hints for Novel Therapies. | Cancers (Basel) | 2023 | 36980798 | PubTator, text mining | PubMed |
| Addressing Natural Killer Cell Dysfunction and Plasticity in Cell-Based Cancer Therapeutics. | Cancers (Basel) | 2023 | 36980629 | PubTator, text mining | PubMed |
| The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer-Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy. | Cancers (Basel) | 2023 | 36980527 | PubTator, text mining | PubMed |
| Persistent CD8 T Cell Marks Caused by the HCMV Infection in Seropositive Adults: Prevalence of HLA-E-Reactive CD8 T Cells. | Cells | 2023 | 36980230 | PubTator, text mining | PubMed |
Spatiotemporally deciphering the mysterious mechanism of persistent HPV-induced malignant transition and immune remodelling from HPV-infected normal cervix, precancer to cervical cancer: Integrating single-cell RNA-sequencing and spatial transcriptome. | Clin Transl Med | 2023 | 36967539 | PubTator, text mining | PubMed |
| Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers. | Mol Cancer | 2023 | 36941614 | PubTator, text mining | PubMed |
| Single-cell profiling identifies a novel human polyclonal unconventional T cell lineage. | J Exp Med | 2023 | 36939517 | PubTator, text mining | PubMed |
| Integrated whole-genome gene expression analysis reveals an atlas of dynamic immune landscapes after myocardial infarction. | Front Cardiovasc Med | 2023 | 36937942 | PubTator, text mining | PubMed |
| Natural killer cells in COVID-19: from infection, to vaccination and therapy. | Future Virol | 2023 | 36936055 | PubTator, text mining | PubMed |
| Genetic susceptibility to severe COVID-19. | Infect Genet Evol | 2023 | 36934789 | PubTator, text mining | PubMed |
| Control of human cytomegalovirus replication by liver resident natural killer cells. | Nat Commun | 2023 | 36918610 | PubTator, text mining | PubMed |
| Roles of Virtual Memory T Cells in Diseases. | Immune Netw | 2023 | 36911806 | PubTator, text mining | PubMed |
| Human CD8+ T-Cell Populations That Express Natural Killer Receptors. | Immune Netw | 2023 | 36911797 | PubTator, text mining | PubMed |
| Transcriptional reprogramming of natural killer cells by vaccinia virus shows both distinct and conserved features with mCMV. | Front Immunol | 2023 | 36911702 | PubTator, text mining | PubMed |
| Activation of immune signals during organ transplantation. | Signal Transduct Target Ther | 2023 | 36906586 | PubTator, text mining | PubMed |
| How Does Vitamin D Affect Immune Cells Crosstalk in Autoimmune Diseases? | Int J Mol Sci | 2023 | 36902117 | PubTator, text mining | PubMed |
| Activating NKG2C Receptor: Functional Characteristics and Current Strategies in Clinical Applications. | Arch Immunol Ther Exp (Warsz) | 2023 | 36899273 | PubTator, text mining | PubMed |
| Life stressors and immune aging: Protective effects of cognitive reappraisal. | Brain Behav Immun | 2023 | 36893924 | PubTator, text mining | PubMed |
| Cytotoxic CD161-CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosus. | EBioMedicine | 2023 | 36893588 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3822/papers?page=20